Articles tagged with Covid 19 Vaccines
Researchers have found that experimental vaccines, including a protein-based vaccine candidate with an adjuvant, provide superior protection against lung disease and higher levels of neutralizing antibodies compared to mRNA vaccines. The results inform the optimization and development of COVID-19 vaccines for young infant populations.
Research found that while broad T-cell response against SARS-CoV-2 spike protein is currently protective, recognition of seven out of ten T-cell targets mutated in COVID-19 variants is impaired. The study suggests ongoing mutation could lead to decreased overall immune system protection.
A large study from Argentina found that COVID-19 vaccines remain effective in preventing death in children and adolescents, regardless of the predominant circulating variant. The study's results show that vaccinated children had a 67% reduced risk of death related to COVID-19 infection during the omicron period.
A global Phase 2/3 clinical trial found that vaccination with SCB-2019 reduced the risk of transmitting SARS-CoV-2 infection to household members. The study showed a significant reduction in symptomatic cases among vaccinated household contacts and indicated that vaccines can play an important role in controlling future outbreaks.
A Brazilian team developed an electrochemical immunosensor to detect SARS-CoV-2 antibodies, achieving 88.7% sensitivity and 100% specificity in just five minutes. The device can be adapted for other diseases and has potential for monitoring seroconversion and seroprevalence.
Researchers found that antibodies against one of the two main domains of the SARS-CoV-2 viral entry machinery elicit a broad antibody response against many variants. This suggests strategies for clinical development of variant-resistant vaccines.
Researchers at Texas A&M University engineered DARPins to block the interaction between the COVID-19 virus and host cells, significantly reducing disease progression. The nasal sprays showed effectiveness against various variants, including omicron, and could provide a lower-cost therapeutic option for those at high risk.
Healthcare workers in Massachusetts prefer strategies supporting education, trust in community-based communication, and accessibility of vaccination sites to increase COVID-19 vaccine and booster rates. These approaches were seen as more effective than mandates or incentives in improving vaccination uptake.
A community pharmacy-led vaccination scheme in South East London successfully supported over 6,000 patients to overcome initial hesitancy around Covid-19 jabs. The programme, which ran for six months, found that a lack of understanding about the vaccine was the biggest reason for patients' hesitation.
A Rutgers study found that COVID-19 patients, especially those treated with antibiotics, experience significant disruptions in their gut microbiome balance. This imbalance may lead to the development of targeted probiotic supplements to improve treatment outcomes.
A recent study found that the proportion of COVID-19 deaths among young people increased in 2021 compared to 2020, resulting in a 7.4% rise in Years of Life Lost due to the virus. The median age of COVID-19 deaths decreased from 78 years in 2020 to 69 years in 2021.
Researchers from UCSF and the San Francisco VA Health Care System found that veterans with PTSD had an 8% increased risk of death and a 9% increased risk of hospitalization compared to those without psychiatric diagnoses. Patients with psychosis had a 58% increased risk of death and a 66% increased risk of hospitalization.
Three circulating omicron subvariants have shown improved resistance to vaccine- and infection-generated neutralizing antibodies. BQ.1 and BQ.1.1 are dominating US infections, while BA.2.75.2 is the best at evading neutralizing antibodies.
A new study published in PLOS Medicine found that COVID-19 vaccination provides significant protection against reinfection, with varying levels of effectiveness (60-94%) across different variants. The study analyzed data from over 200,000 people in Denmark and showed that vaccination offered up to 71% protection during the Alpha period...
A team from UNIGE has revealed the existence of a hidden 'pocket' on the surface of the non-structural protein Nsp1, which could be used to develop new treatments against Covid-19. This discovery paves the way for innovative therapies targeting the Nsp1 protein and its potential application against other coronaviruses.
A systematic review of 36 studies found that influenza vaccination reduced the risk of SARS-CoV-2 infection by 20% and poor outcomes like ICU admission and death by 17-31%. The findings suggest that routine influenza vaccination could offer non-specific immunity against COVID-19 symptoms.
The study found that COVID-19 vaccination in New York City reduced severe outcomes and avoided substantial economic losses. Every dollar invested yielded estimated savings of $10.19 in health costs.
A large study found that mRNA vaccines increased myocarditis risk in younger males, especially after the second dose. Absolute rates were low, with higher observed rates compared to expected rates.
Outreach messages via electronic health record patient portals increased well child care visit scheduling and COVID-19 vaccine receipt in a randomized clinical trial of 945 patients. This tool may help restore delayed well child care in populations affected by the pandemic.
A study found that NFL fan attendance was associated with increased COVID-19 incidence in the host county and surrounding areas. The findings suggest that large events require extra precautions when vaccines, testing, and countermeasures are not readily available.
The FDA's investigation into its own oversight of clinical trials reveals a concerning lack of surveillance, leaving room for scientific misconduct. Experts argue that the agency should inspect sites more frequently to ensure data quality and integrity.
Parental COVID-19 vaccination was associated with lower risk of hospitalization in children under 5, supporting widespread vaccination recommendations for young children. The study's results reinforce the importance of parental immunization during high-risk periods.
Researchers have developed a new nasal vaccine that induces potent lung immunity and protects against SARS-CoV-2 infection in mice. The vaccine approach, which targets the nose, airways, and lungs, has shown promising results in preventing COVID-19 infection.
A nationwide survey in Germany found that 82% of medical and nursing personnel were vaccinated at least once, with 75% having received two doses. In contrast to the general population, unvaccinated healthcare workers had stronger concerns about vaccine safety and effectiveness. The study suggests a need for targeted measures to convinc...
A new study reveals that COVID-19 causes a significant disruption in vaginal microbiota balance, leading to an increased risk of preterm birth. The research found a 70% change in microbiota and higher levels of pathogenic bacteria in infected women compared to control groups.
A study analyzing seroprevalence data found that global COVID-19 infection rates are likely higher than reported, with 59.2% of the population seropositive as of September 2021. The study suggests that two-thirds of the global population may have antibodies from vaccination or infection.
A study by Children's Hospital of Philadelphia researchers found that COVID-19 vaccination results in higher antibody concentrations compared to natural infection, providing robust protection for mothers during pregnancy. The study also suggests optimal vaccine timing can maximize the transfer of antibodies to babies.
A new study found that racial resentment significantly motivates Americans to express confidence in misinformed beliefs about policy issues associated with race, such as human-caused climate change and COVID-19 origins. In contrast, this effect was not observed for less racially charged topics like childhood vaccine safety.
A study found that media literacy and trust in health experts are more powerful predictors of COVID-19 vaccine intentions than previous behavior or knowledge. Researchers also discovered that people who refused flu vaccines had lower future vaccine intentions despite higher COVID-19 knowledge.
A pre-pandemic conspiratorial mindset was associated with hesitance to accept COVID-19 vaccines, a new study suggests. Individuals who held conspiracy theories prior to the pandemic were more likely to believe in COVID-19 conspiracy theories and report hesitancy to be vaccinated.
Researchers mapped out variations in vaccine distribution policies among 29 countries, highlighting differing priorities such as age, comorbidities, and occupation. The study suggests that vaccination schedules differ from resource allocation strategies in healthcare, reflecting diverse moral judgments underlying each approach.
A new study confirms that COVID-19 deaths among children and young people are rare, with most fatalities occurring in those with severe neurodisability or compromised immune systems. The analysis of detailed data showed that half of COVID-19 deaths occurred within 30 days of infection.
A recent study by the Universities of Bonn and Shanxi found that Covid-19 vaccination stimulates immune response, enabling anti-PD-1 therapy to work better against nasopharyngeal cancer. Vaccinated patients responded significantly better to cancer therapy than unvaccinated counterparts.
A new study from Rice University found that Latino communities are hesitant to get vaccinated against COVID-19 due to concerns over side effects and mistrust of health officials. The study, which focused on communities near the U.S.-Mexico border, found that 44% of community health workers reported patients believing vaccines can have ...
Researchers found significant decline in vaccine confidence among adults since pre-pandemic surveys, regardless of age, gender, education, and ethnicity. Post-pandemic participants reported a fall in confidence in vaccines, with nearly one in four experiencing a decrease.
A study found that males younger than 40 years old who received the Moderna COVID-19 vaccine had the highest rates of myocarditis, but overall cases are rare. The study suggests that choosing specific vaccines for certain populations may maximize benefits and minimize adverse events.
A comparative epidemiological analysis found a significant decrease in SARS-CoV-2 outbreaks and cases in German care homes following the introduction of COVID-19 vaccination. The median number of cases/outbreaks fell from 21 to 8, while the case-fatality rate decreased from 15.7% to 10.0%.
The study, led by C. Buddy Creech, MD, MPH, shows the vaccine is safe and generates robust immune responses in young children, providing protection against COVID-19-related hospitalization and death. The findings echo previous results, which found the vaccine to be effective in older children.
A population-level study found that COVID-19 vaccine doses 2-3 were associated with a higher relative risk but small absolute increase in glomerular disease relapse. Most flares were mild, and the benefits of vaccination outweighed the risks.
Researchers identified specific monkeypox mutations that contribute to its continued infectiousness. The virus is accumulating mutations where drugs and antibodies from vaccines are supposed to bind, making it smarter and more infectious.
A comprehensive review and meta-analysis found that young adults under 40 have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination. The analysis analyzed data from over 58 million participants and explored the relationship between COVID-19 vaccine and these rare but dangerous adverse reactions.
A new study led by Duke-NUS Medical School scientists found that inactivated SARS-CoV-2 vaccines elicit a broad immune response against different proteins on the virus, while mRNA vaccines stimulate a single spike protein response. This broader T-cell response may be beneficial in preventing severe COVID-19 disease.
A UCLA study found that Black Americans' mistrust of medical professionals and lower vaccination rates are linked to poor healthcare experiences, not past injustices. Researchers call for changes within the medical community to build better trust with Black patients.
Recent scientific studies have shed light on the effects of exposure to earlier SARS-CoV-2 forms on immune response to Omicron variants. Researchers identified a pan-variant antibody with ultra-potent neutralizing potency, which may help reduce treatment resistance.
The Annenberg Science and Public Health Knowledge Monitor assesses public knowledge on climate, maternal health, vaccination, and more. The quarterly survey reports aim to highlight strengths and weaknesses in public knowledge and inform public health strategies.
A recent study by West Virginia University sociologists found that individuals with paranormal beliefs are more likely to be hesitant about vaccination. These beliefs, which include astrology and spirits, lead to a lack of confidence in science and vaccines, including the COVID-19 shot.
A study published in The BMJ found a small increased risk of thrombosis with thrombocytopenia syndrome (TTS) after vaccination against the Covid-19 virus, particularly with adenovirus vaccines. Researchers recommend considering these risks when planning future immunization campaigns and vaccine development.
A multistate study found that mRNA COVID vaccines were less effective in immunocompromised adults, with protection rates ranging from 34% to 71% after multiple doses. The study emphasizes the importance of non-pharmaceutical interventions, such as masks and antibody treatment, for additional protection against severe COVID-19.
A review of COVID-19 and other adult vaccination efforts found that cash transfers and lottery programs had limited outcomes in increasing vaccination rates, with some studies showing a slight over 2% increase in coverage. Non-cash incentives also showed no significant impact on vaccination uptake.
Researchers found that two-dose CoronaVac vaccination schedules, spaced 2 or 4 weeks apart, elicit similar immune responses against SARS-CoV-2 variants. The study suggests that either schedule can provide equal protection against COVID-19.
Researchers have developed an intranasal COVID-19 vaccine that works against the original virus and two variants, including omicron, in hamsters. The vaccine stimulates a strong immune response both systemically and in the respiratory tract.
A new study by the University of Waterloo found that individuals with anxiety disorders are not more hesitant to get vaccinated than those without. Instead, discomfort with uncertainty is a significant predictor of vaccine hesitancy in both anxious and non-anxious individuals.
Research suggests that regular physical activity enhances vaccine effectiveness against COVID-19 by improving antibody levels and mitochondrial function. High levels of physical activity were associated with higher vaccine protection rates, with significant reductions in hospital admissions and severe illness risk.
A recent literature review found that vaccination against SARS-CoV-2 can effectively prevent adverse conditions such as stillbirth and infant death. Pregnant women with COVID-19 have an increased risk for stillbirth compared to uninfected women, and those who vaccinate can more effectively prevent these events.
A nationwide study found that mRNA vaccines significantly reduced the severity of Delta and Omicron COVID-19 infections in vaccinated individuals. The study, involving over 1,199 participants, also showed that breakthrough cases were more likely with Delta and Omicron variants but still limited by the vaccine's effectiveness.
A retrospective study of 26,000 patients with cirrhosis found that receiving a third dose of the COVID-19 vaccine reduced overall and severe cases by 80% and 100%, respectively. This suggests that a third dose can overcome vaccine hyporesponsiveness in patients with cirrhosis.
Researchers analyzed COVID-19 conspiracy theories on Twitter, finding that some peaked at the beginning of the pandemic while others remained persistent throughout. The study suggests that risk perceptions and lack of information from governments and experts contributed to the persistence of these theories.
A survey of six European countries found strong public support for transferring COVID-19 vaccines to poorer nations and prioritizing those with the greatest need. Europeans consistently prioritized individuals most vulnerable, employed individuals, or those who lost income during the pandemic over unemployed individuals.
A study of 7,800 children under 5 years old found comparable side effects between Pfizer-BioNTech and non-COVID-19 vaccines. The results could inform vaccination recommendations for this age group.
The US ranks last in vaccination rates among the world's richest countries, with a mortality rate from COVID-19 30 times higher than influenza. Boosters can reduce the risk of dying and hospitalization by over 90%. All US adults and eligible children should receive booster shots to protect against future variants.